EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›MYSZ

MYSZ

My Size, Inc.

Next earnings ≈ Aug 13, 2026 · est. from filing cadence

Last earnings -1.9% on 2026-05-15

Sell
$0.46
▲ +5.18%
$0.46▼ -58.82%
over 1Y
L $0.41EODHDH $1.44
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.2%
1W-0.9%
1M-9.0%
3M-22.9%
YTD-43.9%
1Y-58.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Flagged
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue grew 13.4% YoY; but unprofitable (net margin -62.5%).

Revenue (FY2025) $9.36M · FY2025

My Size, Inc. shows $9.36M in FY2025 revenue (+13.4% YoY), a -62.5% net margin, and -113.5% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$131K$4.46M$7.00M$8.26M$9.36M
Gross profit$131K$634K$2.73M$3.32M$3.00M
Operating income-$10.6M-$8.11M-$6.74M-$3.94M-$5.74M
Net income-$10.5M-$8.31M-$6.38M-$4.00M-$5.85M
Diluted EPS—-$7.47-$20.40-$4.39-$1.87
Net margin-8030.5%-186.4%-91.2%-48.4%-62.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$814K
EV / EBITDA—
EV / Sales0.1
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-266.9%
FCF yield-235.3%

Quality & risk

ROIC (est.)-74.6%
Free cash flow-$5.16M
Total debt$925K
Net cash$1.38M
Altman Z-Score-9.82 distress
Piotroski F-Score2/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+128.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — late filing notice (2026-03-31). Worth a closer look.
  1. DEF 14A Proxy statement2026-06-02
  2. 8-K Earnings results2026-05-15
  3. 10-Q Quarterly report2026-05-14
  4. 10-K Annual report2026-04-15
  5. NT 10-K Late filing notice2026-03-31
  6. 8-K Earnings results2026-03-03
  7. 8-K Delisting notice2026-03-02
  8. 8-K Earnings results2025-12-29
  9. 8-K Officer / director change2025-12-19

Recent filings

all on EDGAR ↗
ARSPeriod ending 2025-12-312026-06-02open ↗DEFA14AFiling2026-06-02open ↗DEF 14APeriod ending 2026-06-022026-06-02open ↗PRE 14APeriod ending 2026-05-212026-05-21open ↗8-KPeriod ending 2026-05-152026-05-15open ↗10-QPeriod ending 2026-03-312026-05-14open ↗10-KPeriod ending 2025-12-312026-04-15open ↗NT 10-KPeriod ending 2025-12-312026-03-31open ↗8-KPeriod ending 2026-03-032026-03-03open ↗8-KPeriod ending 2026-03-022026-03-02open ↗4Period ending 2025-12-292025-12-30open ↗8-KPeriod ending 2025-12-292025-12-29open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthD
ProfitabilityF
Financial healthC+
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$9.36M
+13.4% YoY
Net margin
-62.5%
ROE
-113.5%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$9.36M+13.4%
Net income-$5.85M-46.5%
Gross profit$3.00M-9.7%
Operating income-$5.74M-45.5%
Diluted EPS-$1.87+57.4%
Cash & equivalents$2.30M-52.8%
Total assets$10.2M+1.4%
Total liabilities$5.05M+60.2%
Stockholders' equity$5.16M-25.4%
Gross: 32.0%Op.: -61.3%L/E: 0.98x

Frequently asked

Is My Size, Inc. (MYSZ) a buy?
MYSZ currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 13.4% YoY; but unprofitable (net margin -62.5%).
What is My Size, Inc.'s quality score?
MYSZ scores 54.05882352941176/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001211805, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 1:11:02 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-12-29
Luzon Ronen
Chief Executive Officer
Buy3.75K @ $0.78$2.92K
2025-12-15
Luzon Ronen
Chief Executive Officer
Award215K
2025-12-15
Luzon Ronen
Chief Executive Officer
Award60.0K
2025-12-15
Branitzky Oron
Director
Award15.0K
2025-12-15
Elmaliah Oren
Chief Financial Officer
Award30.0K
2025-12-15
Cembrero Saralegui Borja
Chief Growth Officer
Award110K
2025-12-15
Pardo Billy
CPO & COO
Award60.0K
2025-12-15
Pardo Billy
CPO & COO
Award215K
2025-12-15
Zimmerman Guy
Director
Award15.0K
2025-12-15
Golan Roy
Director
Award15.0K

Earnings history

beat/miss · move
2026-05-15—▼ -1.89%8-K ↗
2026-03-03Miss -166.5% est▲ +0.56%8-K ↗
2025-12-29—▼ -2.79%8-K ↗
2025-11-14—▼ -3.60%8-K ↗
2025-08-15—▼ -4.80%8-K ↗
2025-03-28Beat +72.9% est▲ +42.06%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Size and Fit Prediction Artificial intelligence (AI) Research Report 2025: $2.95 Bn Market Opportunities, Trends, Competitive Analysis, Strategies, and Forecasts, 2019-2024, 2024-2029F, 2034FBullish
globenewswire.com· 2026-01-29
Percentil a subsidiary of MySize Expands Second-Hand Fashion Distribution Across Europe Through Amazon MarketplaceBullish
finance.yahoo.com· 2026-01-28
MySize reports Q3 resultsBearish
seekingalpha.com· 2025-11-14
MySize Inc. Expands Naiz Fit Platform with Acquisition of ShoeSize.Me, Adding AI-Powered Footwear Sizing to Its Fashion Tech Roll-Up StrategyBullish
finance.yahoo.com· 2025-09-11
MySize reports Q2 resultsBullish
seekingalpha.com· 2025-08-15
My Size stock soars after successful launch of NaizGPT retail AI assistantBullish
investing.com· 2025-07-30

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score54 vs 67
Revenue growth13.4% vs 7.1%
Net margin-62.5% vs 10.5%
Return on equity-113.5% vs 12.3%
P/E— vs 25.5